Surface Oncology, Inc. Recorded Big Gain
Wed, May 20, 2020 at 05:30 PM
Surface Oncology, Inc. (SURF:NASDAQ) shot up at $3.88, a gain of 45.9%. On Tue 19 May 20, SURF:NASDAQ hit a New 2-Week Intraday High of $2.84. The stock got featured on our News Catalysts scanner on Wed 20 May 20 at 08:08 AM in the 'MERGER' category. From Tue 05 May 20, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Surface Oncology, Inc. (SURF:NASDAQ)
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
Top 10 Gainers:
- Phunware, Inc. (PHUN:NASDAQ), 134.43%
- Cinedigm Corp. (CIDM:NASDAQ), 104.84%
- Renren Inc. (RENN:NYSE), 81.4%
- Boxlight Corporation (BOXL:NASDAQ), 57.54%
- Cheetah Mobile Inc. (CMCM:NYSE), 47.34%
- Surface Oncology, Inc. (SURF:NASDAQ), 45.86%
- GigaMedia Limited (GIGM:NASDAQ), 41.94%
- China HGS Real Estate Inc. (HGSH:NASDAQ), 40.99%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 38.96%
- China Ceramics Co., Ltd. (CCCL:NASDAQ), 38.85%